LINC01137

Across TCGA pan-cancer cohorts, LINC01137 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC01137 data layer.

The strongest signal is observed in brain lower grade glioma (LGG), where higher LINC01137 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01137 expression acts as an unfavorable survival marker, although some lineages such as ESCA and THCA show a favorable association.

LGG, ESCA, and PAAD are the cancer types where LINC01137 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	OS	Median	All	0.330	0.527	<.001	50	view →
ESCA	DFS	Quartile	All	0.452	0.240	.004	33	view →
PAAD	DFS	Median	All	0.192	0.386	.001	32	view →
LUAD	OS	Median	All	0.277	0.453	.005	31	view →
THYM	OS	Median	All	0.683	1.000	.006	24	view →
UCS	OS	Median	IV	0.224	0.732	.018	24	view →
THCA	OS	Quartile	III,IV	1.000	0.595	.013	23	view →
COAD	OS	Median	III,IV	0.668	0.275	.002	23	view →
LIHC	OS	Median	All	0.390	0.619	.001	23	view →
OV	DFS	Quartile	III,IV	0.323	0.432	.007	18	view →
LAML	DFS	Quartile	All	0.148	0.637	<.001	18	view →
MESO	DFS	Quartile	III,IV	0.141	0.676	.010	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC01137–LGG (OS)

Open the LGG breakdown →